Search images on Google Product Monograph
Active Ingredients:
- cabotegravir, 200 MG/ML
- rilpivirine, 300 MG/ML
DIN: 02497220
Dosage Form(s): SUSPENSION (EXTENDED-RELEASE), KIT
Route(s) of Administration: INTRAMUSCULAR
Description: KIT CONTAINS 2 ML VIAL OF CABOTEGRAVIR AND 2 ML VIAL OF RILPIVIRINE
Schedule: Prescription
Company: VIIV HEALTHCARE ULC
ATC:
- J05 - ANTIVIRALS FOR SYSTEMIC USE (ATC, WHO, Wiki)
- J05A - DIRECT ACTING ANTIVIRALS (ATC, WHO)
- J05AR - Antivirals for treatment of HIV infections, combinations (ATC, WHO)
- J05AR - ANTIVIRALS FOR TREATMENT OF HIV INFECTIONS, COMBINATIONS (WHO)